Gattex (teduglutide) — Blue Cross Blue Shield of Kansas
Short Bowel Syndrome (SBS) in adults and pediatric patients ≥ 1 year of age who are dependent on parenteral support
Initial criteria
- Target agent(s) will be approved when ALL of the following are met:
- 1. ONE of the following: